在急性胰腺炎指南中加入明确提示可提高对淀粉酶检测建议的依从性
该研究在坎特伯雷地区卫生局(CDHB)医院的在线临床指南 Hospital HealthPathways 的急性胰腺炎指南中加入一条「实践要点」,明确建议避免连续检测血清淀粉酶。采用前后对照设计:加入前6个月(截至加入前3个月)的数据为对照组,加入后6个月(自加入后3个月起)的数据为实验组,审计全科医生、急诊科、普外科及其他科室为急性胰腺炎入院患者开具的血清淀粉酶检测次数。结果显示,加入实践要点前126例患者中82例(65%)仅在入院时测一次淀粉酶,加入后182例中142例(78%)仅测一次,依从性提高13%;改善见于全科医生直接转诊至普外科团队的患者及其他专科管理的患者。实验组6个月内依从性存在显著波动,但未显示明确的改善或衰减趋势。作者认为,简单澄清指南中的关键点即可对依从性产生显著正面影响,这对指南作者和发布机构具有重要参考价值。
要点
- 在急性胰腺炎在线指南中加入「避免连续检测血清淀粉酶」的实践要点后,仅测一次淀粉酶的患者比例由65%(82/126)升至78%(142/182),依从性提高13%。
- 改善主要见于全科医生直接转诊至普外科团队的患者,以及其他专科管理的患者。
- 实验组6个月观察期内依从性存在显著波动,但未显示明确的改善或衰减趋势。
- 作者认为,简单澄清指南中的关键点即可对依从性产生显著正面影响,提示指南作者和发布机构应重视指南中关键点的明确表述。
适用人群与场景
- 因急性胰腺炎入院、由全科医生、急诊科医生、普外科医生及其他科室医生开具血清淀粉酶检测的患者。
处置流程与药物剂量
- 在急性胰腺炎在线指南中加入「实践要点」,明确提示避免连续检测血清淀粉酶,仅入院时测一次。
研究设计与关键结果
- 研究类型为前后对照的审计研究,对照组为加入实践要点前6个月(截至加入前3个月)的数据,实验组为加入后6个月(自加入后3个月起)的数据。
- 加入实践要点前,126例患者中82例(65%)仅在入院时测一次淀粉酶,符合 Hospital HealthPathway 指南;加入后,182例中142例(78%)仅测一次,依从性提高13%。
- 改善见于全科医生直接转诊至普外科团队的患者及其他专科管理的患者;实验组6个月内依从性波动显著,但无明确改善或衰减趋势。
证据类型、等级与局限
- 证据类型为前后对照的审计研究;局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在在线临床指南中加入明确关键点的简单干预可显著改善依从性,对指南作者和发布机构有参考价值;该干预可能有助于改善以患者为中心、财务和临床方面的结局。
指南或共识出处
- Hospital HealthPathways 急性胰腺炎指南(坎特伯雷地区卫生局在线临床指南数据库)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: Hospital HealthPathways is an online database of local clinical guidelines produced by a dedicated team for use within Canterbury District Health Board (CDHB) hospitals. A 'Practice Point'-a bullet point making explicit a recommendation within the body of a clinical guideline-was added to the guideline for acute pancreatitis, instructing users to avoid serial measurements of serum amylase levels. The aim was to explore whether the addition of this Practice Point affected compliance with the amylase measurement recommendations.
METHOD: The number of serum amylase tests requested for patients admitted with acute pancreatitis by GPs and doctors working in the emergency department, general surgery and other departments was audited using the CDHB's online clinical information system. A data set from a six-month period ending three months prior to the addition of the Practice Point, collected for a previous study, was used with the author's permission as a control group. A new data set from a six-month period starting three months after the addition of the Practice Point formed the experimental group.
RESULTS: Compliance rose by 13% after the addition of the Practice Point. Before the Practice Point was added to the guideline, 82 of 126 total patients (65%) had amylase measured only once, on admission, in compliance with the Hospital HealthPathway guideline. After the addition of the Practice Point, 142 of 182 patients (78%) had one measurement of amylase. This improvement was seen where patients were referred directly by their GP to the general surgical teams and patients managed by other specialties. Variation in compliance seen over the six-month experimental group period was significant, but did not show a clear trend of either improvement or decay in compliance.
CONCLUSION: This supports the hypothesis that the simple intervention of clarifying a key point within a clinical guideline can have a significant positive effect on compliance. This is an important consideration for guideline authors and institutions publishing clinical guidelines, as poor compliance by clinicians is reported in studies. The intervention in this study is a simple change for guidelines based online, and the significant effect could contribute to improvement in patient-centred, financial and clinical domains.
参考来源
- Maidlow SC, Ardagh M, Callender R, et al. Addition of explicit guidance to acute pancreatitis guidelines increases compliance with amylase measurement recommendations. N Z Med J. 2019. PMID: 30703782
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。